← Back to Screener
Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT)
Price$0.80
Value ScoreB
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-77.35%
Price vs S&P 500 (4W)-14.14%
VGM Score40.49
Market Capitalization$3.46M
P/E Ratio (Annual)28.23x
All Metrics
P/CF (Annual)11.91x
Book Value / Share (Quarterly)$0.81
P/TBV (Annual)1.89x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)664.65%
Cash Flow / Share (Quarterly)$0.00
Payout Ratio (TTM)78.85%
Price vs S&P 500 (YTD)-42.69%
Gross Margin (TTM)24.21%
Net Profit Margin (TTM)-51.18%
EPS (TTM)$-0.28
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-0.28
EPS (Annual)$-0.22
Dividend / Share (Annual)$0.00
ROI (Annual)-21.51%
Gross Margin (Annual)20.51%
Net Profit Margin (5Y Avg)6557.38%
Cash / Share (Quarterly)$0.17
Revenue Growth QoQ (YoY)-37.56%
P/E Normalized (Annual)28.23x
ROA (Last FY)-15.99%
Revenue Growth TTM (YoY)-4.17%
EBITD / Share (TTM)$-0.23
ROE (5Y Avg)4.14%
Operating Margin (TTM)-55.62%
Cash Flow / Share (Annual)$0.00
P/B Ratio0.64x
P/B Ratio (Quarterly)1.48x
Net Income / Employee (Annual)$-37,161
Net Interest Coverage (TTM)-19.60x
ROA (TTM)-19.44%
EPS Incl Extra (Annual)$-0.22
Current Ratio (Annual)1.14x
Quick Ratio (Quarterly)0.80x
3-Month Avg Trading Volume0.16M
52-Week Price Return-91.38%
EV / Free Cash Flow (Annual)260.47x
Revenue / Employee (TTM)$95,168
Tangible BV / Share (Quarterly)$0.63
P/S Ratio (Annual)1.36x
Asset Turnover (Annual)0.27x
52-Week High$13.08
Operating Margin (5Y Avg)9304.42%
EPS Excl Extra (Annual)$-0.22
26-Week Price Return-63.76%
Quick Ratio (Annual)0.80x
13-Week Price Return2.64%
Total Debt / Equity (Annual)0.30x
Current Ratio (Quarterly)1.14x
Enterprise Value$27.01M
Asset Turnover (TTM)0.38x
Revenue / Employee (Annual)$61,975
Inventory Turnover (Annual)1.90x
Pretax Margin (Annual)-61.77%
Cash / Share (Annual)$0.17
3-Month Return Std Dev152.02%
Gross Margin (5Y Avg)22493.12%
Net Income / Employee (TTM)$-48,712
ROE (Last FY)-27.93%
Net Interest Coverage (Annual)-16.12x
EPS Basic Excl Extra (Annual)$-0.22
P/FCF (TTM)10.36x
Receivables Turnover (TTM)3.45x
EV / Free Cash Flow (TTM)260.47x
Total Debt / Equity (Quarterly)0.30x
EPS Incl Extra (TTM)$-0.28
Receivables Turnover (Annual)2.25x
ROI (TTM)-25.79%
P/S Ratio (TTM)0.89x
Pretax Margin (5Y Avg)9040.83%
Revenue / Share (Annual)$0.36
Tangible BV / Share (Annual)$0.63
Price vs S&P 500 (52W)-119.53%
Year-to-Date Return-31.30%
5-Day Price Return-8.85%
EPS Normalized (Annual)$-0.22
ROA (5Y Avg)2.40%
Net Profit Margin (Annual)-59.97%
Month-to-Date Return-7.08%
EBITD / Share (Annual)$-0.14
EPS Growth (3Y)528.02%
Operating Margin (Annual)-60.59%
LT Debt / Equity (Annual)0.04x
P/CF (TTM)11.91x
ROI (5Y Avg)3.75%
LT Debt / Equity (Quarterly)0.04x
EPS Basic Excl Extra (TTM)$-0.28
P/TBV (Quarterly)1.89x
Payout Ratio (Annual)141.66%
P/B Ratio (Annual)1.48x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)2.78x
Pretax Margin (TTM)-57.51%
Book Value / Share (Annual)$0.81
Price vs S&P 500 (13W)-8.03%
Dividend Yield (TTM)0.00%
Beta-0.64x
P/FCF (Annual)225.88x
Revenue / Share (TTM)$0.56
ROE (TTM)-33.33%
52-Week Low$0.68
vGradeB
gGradeD
mGradeD
vgmGradeC
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ZYBTZhengye Biotechnology Holding Limited Class A Ordinary Shares | B | D | D | $0.80 |
| LLYEli Lilly & Co. | D | B | B | $1078.78 |
| JNJJohnson & Johnson | C | C | C | $223.24 |
| ABBVABBVIE INC. | D | C | C | $217.13 |
| MRKMerck & Co., Inc. | C | C | C | $114.70 |
| AZNAstraZeneca PLC | D | B | C | $176.28 |
| NVSNovartis AG | C | C | C | $143.66 |
| NVONovo-Nordisk A/S | B | B | B | $42.00 |
| ABTAbbott Laboratories | C | C | D | $86.99 |
| PFEPfizer Inc. | B | C | C | $25.34 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $32.83 |
About
Zhengye Biotechnology manufactures and distributes veterinary vaccines primarily for livestock, with swine and poultry vaccines generating the majority of revenue. The company offers a diverse product range including vaccines for cattle, goats, sheep, waterfowl, and pets, sold across Chinese provinces and exported to Vietnam, Pakistan, and Egypt.